The Misuse of Drugs Act 1971 (Modification) Order 1996

Statutory Instruments

1996 No. 1300

DANGEROUS DRUGS

The Misuse of Drugs Act 1971 (Modification) Order 1996

Made

15th May 1996

Coming into force

1st September 1996

At the Court at Buckingham Palace, the 15th day of May 1996

Present,

The Queen’s Most Excellent Majesty in Council

Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament:

Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 1971(1), is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:

1.  This Order may be cited as the Misuse of Drugs Act 1971 (Modification) Order 1996 and shall come into force on 1st September 1996.

2.—(1) Schedule 2 to the Misuse of Drugs Act 1971(2) (which specifies the drugs which are subject to control under that Act) shall be amended as follows.

(2) In paragraph 1 of Part III of that Schedule

(a) the list of substances and products beginning with“Alprazolam”and ending with “Triazolam”shall be designated sub-paragraph (a), and accordingly “(a)”shall be inserted before “Alprazolam”; and

(b) there shall be added at the end the following sub-paragraphs —

“(b) Atamestane.

• Bolandiol.

• Bolasterone.

• Bolazine.

• Boldenone.

• Bolenol.

• Bolmantalate.

• Calusterone.

• 4-Chloromethandienone.

• Clostebol.

• Drostanolone.

• Enestebol.

• Epitiostanol.

• Ethyloestrenol.

• Fluoxymesterone.

• Formebolone.

• Furazabol.

• Mebolazine.

• Mepitiostane.

• Mesabolone.

• Mestanolone.

• Mesterolone.

• Methandienone.

• Methandriol.

• Methenolone.

• Methyltestosterone.

• Metribolone.

• Mibolerone.

• Nandrolone.

• Norboletone.

• Norclostebol.

• Norethandrolone.

• Ovandrotone.

• Oxabolone.

• Oxandrolone.

• Oxymesterone.

• Oxymetholone.

• Prasterone.

• Propetandrol.

• Quinbolone.

• Roxibolone.

• Silandrone.

• Stanolone.

• Stanozolol.

• Stenbolone.

• Testosterone.

• Thiomesterone.

• Trenbolone.

(c) any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i) by further substitution at position 17 by a methyl or ethyl group;

(ii) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv) by fusion of ring A with a heterocyclic system;

(d) any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

(e) Chorionic Gonadotrophin (HCG).

• Clenbuterol.

• Non-human chorionic gonadotrophin.

• Somatotropin.

• Somatrem.

• Somatropin.”.

N. H. Nicholls

Clerk of the Privy Council

Explanatory Note

(This note is not part of the Order)

This Order adds to Part III of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the Class C drugs which are subject to control under the Act) the anabolic and androgenic steroids and derivatives; an andrenoceptor stimulant; and polypeptide hormones specified in article 2(2)(b).

(1)

1971 c. 38.

(2)

Schedule 2 has been amended by S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230, 1989/1340, 1990/2589 and 1995/1966.